Emergent Biosolutions Inc (EBS) gets rating Initiated from H.C. Wainwright

In a filing, Emergent Biosolutions Inc revealed its Director Fowler Neal Franklin unloaded Company’s shares for reported $0.2 million on Mar 12 ’25. In the deal valued at $5.83 per share,35,000 shares were sold. As a result of this transaction, Fowler Neal Franklin now holds 101,100 shares worth roughly $0.58 million.

Then, Zoon Kathryn C sold 10,000 shares, generating $57,300 in total proceeds. Upon selling the shares at $5.73, the Director now owns 44,482 shares.

Before that, Fowler Neal Franklin bought 35,000 shares. Emergent Biosolutions Inc shares valued at $204,005 were divested by the Director at a price of $5.83 per share.

H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.

Price Performance Review of EBS

On Monday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock jump 0.17% to $5.73. Over the last five days, the stock has lost -1.04%. Emergent Biosolutions Inc shares have fallen nearly -40.06% since the year began. Nevertheless, the stocks have risen 128.29% over the past one year. While a 52-week high of $15.10 was reached on 01/24/25, a 52-week low of $1.82 was recorded on 03/04/25. SMA at 50 days reached $8.41, while 200 days put it at $8.75.

Levels Of Support And Resistance For EBS Stock

The 24-hour chart illustrates a support level at 5.60, which if violated will result in even more drops to 5.48. On the upside, there is a resistance level at 5.89. A further resistance level may holdings at 6.06. The Relative Strength Index (RSI) on the 14-day chart is 33.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.02%. Stochastics %K at 35.12% indicates the stock is a holding.

How much short interest is there in Emergent Biosolutions Inc?

A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2025-02-28, growing by 1.21 million shares to a total of 8.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 6.93 million shares. There was a rise of 14.89%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.